Signal
Spatial and molecular profiling advances understanding of tumor heterogeneity and therapy resistance
Evidence first: scan the strongest sources, then decide whether to go deeper.
rss
clinical_trialsr_and_dgenomicssafety_signals
Trend in the last 24h
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Recent studies employing spatial transcriptomics, single-cell proteomics, and network-based analyses have deepened insights into tumor microenvironments and molecular evolution across multiple cancers.
Score total
1.29
Momentum 24h
5
Posts
5
Origins
1
Source types
1
Duplicate ratio
0%
Why now
- New spatial and single-cell technologies enable unprecedented tumor microenvironment resolution.
- Cross-platform RNA data integration addresses challenges in biomarker reproducibility.
- Network-based tumor classification supports personalized treatment strategies.
Why it matters
- Spatial and multiomic profiling reveals tumor heterogeneity critical for precision oncology.
- Identifying therapy resistance mechanisms guides development of targeted combination treatments.
- Integrative biomarker discovery across platforms enhances clinical decision-making.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: high
Recurring claims
- Spatial transcriptomics identifies stage-specific gene expression programs in cutaneous squamous cell carcinoma
- Imaging mass cytometry reveals multicellular niches linked to prognosis in primary prostate cancer
- POSTN+ cancer-associated fibroblasts mediate chemoradiotherapy resistance in rectal cancer
- Cross-assay RNA integration improves biomarker discovery in heterogeneous ovarian cancer
How sources frame it
- Naji Et Al.: neutral
- Martinelli Et Al.: neutral
- Sakai Et Al.: neutral
- Townsend Et Al.: neutral
All evidence
All evidence
Network-based analysis of glioblastoma identifies patient communities and cluster-specific biomarkers
bioRxiv (all subjects) · biorxiv.org · 2026-05-05 20:58 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
- bioRxiv (all subjects) (1)
Top origin domains (this list)
- biorxiv.org (1)